newsfilter
← Latest News
PR Newswire·

Kintara Therapeutics Announces Adjournment of Special Meeting of Stockholders until October 4, 2024

Kintara Therapeutics, Inc. (Nasdaq: KTRA) ("Kintara"), a biopharmaceutical company focused on the development of new solid tumor cancer therapies,...